PRPO
Precipio, Inc.
Diagnostics & Research · Healthcare · United States
26.79
close · 2026-09-21
value
52
cheaper than peers52
quality
56
stronger fundamentals56
ranked against
Diagnostics & Research
value
quality
30 peers
Value inputs
| measure | company | vs peers |
| price to sales | 1.90× | 84 |
| price to book | 3.25× | 63 |
| forward P/E | 68.69× | 13 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 24.2% | 82 |
| debt to equity | 24.3% | 77 |
| operating margin | -8.5% | 36 |
| return on equity | -9.0% | 27 |
4 of 4 measures available
Facts
| market cap | $48M |
| free cash flow | $1.3M |
| employees | 61 |
| first trade | 2017-06-30 |
| next earnings | not reported |
| fundamentals updated | 2026-08-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.23 | -2.93 | -4.51 | -10.73 |
| free cash flow | $359,000 | $216,000 | -$3.7M | -$8.0M |
| net income | -$363,000 | -$4.3M | -$5.9M | -$12.2M |
| revenue | $24.0M | $18.5M | $15.2M | $9.4M |
| unusual items | $789,000 | $0 | $1.7M | $631,000 |